Healthcare

Pharmaceutical giant Pfizer is actively working to secure its future revenue streams as the patent expiration for its blockbuster drug...

Siemens Healthineers is navigating a period of significant strategic change. While its core divisions continue to show robust growth, the...

Investors are preparing for a critical financial update from Healwell AI Inc. The Canadian healthcare artificial intelligence company is scheduled...

The biopharmaceutical company aTyr Pharma is entering a pivotal period for its lead therapeutic candidate, efzofitimod. Two major clinical and...

In a strategic move to bolster its core pharmaceutical business, Novartis has received expanded U.S. regulatory approval for its immunology...

Sensei Biotherapeutics is navigating a significant corporate transformation. The biotechnology firm has recently completed a comprehensive restructuring and integrated new...

After a period of significant price swings, Illumina's shares are showing signs of entering a more stable phase. A growing...

Investors in DuPont de Nemours are witnessing a company in the midst of a significant strategic evolution. As the firm...

The coming months represent a pivotal period for biopharmaceutical firm Axsome Therapeutics. As the company strategically expands its commercial capabilities,...

Following the release of its 2025 annual results, Protara Therapeutics has shifted investor attention squarely to its clinical pipeline. The...